TAT - 12th International Congress on Targeted Anticancer Therapies

March 5 - 7, 2014     Washington, DC

March 05, 2014

March 5 - 7, 2014

 

Washington, DC

http://tatcongress.org/wp-content/uploads/2014/05/tat2014-final-program.pdf 

Poster & Discussion by Dr. Ruby Meredith, principal investigator for AREVA Med's Phase 1 clinical trial with Pb212-TCMC-Trastuzumab

AREVA Med Video

Click here to view the latest AREVA Med Video

Contact

For more information about AREVA Med, please contact:
Alison Tise
Tel.: + 1 (301) 841-1673